Sanara MedTech Inc.SMTI
Price (close)
$35.10
Market cap
$322.5M
P/E
—
Revenue (TTM)
$109.8M
Net income
-$32.0M
Dividend yield
—
1-year total return
12.4%
Net margin
-29.2%
Revenue growth
13.0%
Debt / equity
5.85x
What Sanara MedTech Inc. does.
are a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and
reduce healthcare expenditures in the surgical market. Our products are designed to achieve our goal of providing better clinical outcomes
at a lower overall cost for healthcare systems. We strive to be one of the most innovative and comprehensive providers of effective surgical
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $15.6M | $24.1M | $45.8M | $65.0M | $86.7M | $103.1M |
| Net income | -$4.4M | -$7.9M | -$7.9M | -$4.3M | -$9.7M | -$37.6M |
| Free cash flow | -$4.6M | -$5.0M | -$5.7M | -$3.5M | -$229,632 | $2.2M |
More on SMTI.
- Sanara MedTech Inc. summary
- Sanara MedTech Inc. financial statements
- Sanara MedTech Inc. key metrics
- Sanara MedTech Inc. health scores and style box
- Sanara MedTech Inc. earnings
- Sanara MedTech Inc. dividends
- Sanara MedTech Inc. valuation
- Sanara MedTech Inc. ownership and insiders
- Sanara MedTech Inc. peers
Figures from Sanara MedTech Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.